CEO: Robert Paulson
Key product: Pillar Palatal Implant System, which treats snoring and mild to moderate sleep apnea.
In the news: The latest company to be caught up in the credit crunch because of investments in auction-rate securities.
2007 revenue: $4.1 million, down 30 percent
Share price Thursday: $1.22 (before the news was released)